Blue Jet Healthcare Limited (BOM:544009)

Market Cap	83.91B
Revenue (ttm)	11.79B
Net Income (ttm)	3.52B
Shares Out	n/a
EPS (ttm)	20.31
PE Ratio	23.81
Forward PE	23.44
Dividend	1.20 (0.24%)
Ex-Dividend Date	Sep 19, 2025

Volume	15,216
Average Volume	12,781
Open	490.05
Previous Close	490.60
Day's Range	482.10 - 494.80
52-Week Range	482.95 - 1,028.20
Beta	n/a
RSI	29.08
Earnings Date	Feb 4, 2026

About Blue Jet Healthcare

Blue Jet Healthcare Limited engages in the manufacturing and sale of pharmaceutical intermediates and active pharmaceutical ingredients (APIs) for use in pharmaceutical and healthcare products. It provides contrast media intermediates; niche pharmaceutical intermediates and APIs; and CDMO/CMO services, as well as end-to-end solutions from process development and commercialization of NCEs, advance intermediates, API, and building blocks. The company develops, manufactures, and markets saccharin and related salts. It has operations in India, Norw...

• Industry: Pharmaceutical Preparations
• Founded: 1968
• Employees: 196
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 544009

Financial Performance

In 2024, Blue Jet Healthcare's revenue was 10.30 billion, an increase of 44.74% compared to the previous year's 7.12 billion. Earnings were 3.05 billion, an increase of 86.38%.